January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
Based on market forecasts, the non-invasive prenatal testing sector will expand from USD 6.45 billion in 2024 to USD 18.94 billion by 2034, experiencing a CAGR of 11.65%. The non-invasive prenatal testing market is growing due to the increasing demand for safer, earlier, and accurate detection of fetal genetic disorders. North America is dominating...
November 01, 2025
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of point-of-care testing for infectious diseases in the U.S. is driven by improved patient outcomes, inc...
November 01, 2025
The dental panoramic X-ray market is growing because it is utilized when checking for jaw disorders, wisdom teeth, and issues involving sinuses and oral health. North America is dominant in the market due to its high consumer spending on dental care and huge adoption of advanced modern imaging technologies....
October 29, 2025
Projections indicate that, the global chromatography accessories and consumables market will increase from USD 5.19 billion in 2024 to USD 11.27 billion by 2034, experiencing a CAGR of 8.04% over the next 10 years. Globally, industries are adopting various advanced technological chromatography systems, particularly in pharmaceutical R&D departm...
October 24, 2025
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North America (45.9%) and Asia Pacific. The study covers trade data, supply chain, key players like QIAGEN,...
October 17, 2025
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED tests show high CAGR, and NGS made up 38% of technology revenue. Blood and urine are key sample type...
October 16, 2025
The oncology biomarker market is valued at USD 38.62 billion in 2025 and is projected to reach USD 113.54 billion by 2034, growing at a CAGR of 12.73%. The report covers market segments by biomarker type, including genomic (35% share in 2024) and proteomic biomarkers, application types such as diagnostic testing (50% share in 2024) and prognostic t...
October 08, 2025
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies ...
October 01, 2025
Projections indicate that, biochip industry is projected to rise from USD 12.75 billion in 2024 to USD 42.15 billion by 2034, reflecting a CAGR of 12.7% over the next decade. The biochip market is growing because biochips have many applications, such as medical diagnostics, drug development, personalized medicine, continuous health monitoring, neur...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com